Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
Compositions for affecting weight loss comprising an opioid antagonist and bupropion
No-Receipt date
2017-04308 - 11/12/2017
No-Filing date
20170800060 - 11/12/2017
No-Granting date
8000716 - 27/08/2019
No-EPO application date
-
No-EPO granting date
-
Gazette No-Publication date of application
4/2018 - 27/06/2018
Gazette No-Publication date of granted patent
8/2019 - 25/09/2019
Expiration date
22/04/2029
Kind of title
Supplementary Protection Certificate for Medicinal Products
Legal status
VALID
Priorities
-
Active Substance of Supplementary Certificates
NALTREXONE Ή ΕΝΑ ΦΑΡΜΑΚΕΥΤΙΚΩΣ ΧΡΗΣΙΜΟΠΟΙΟΥΜΕΝΟ (ΑΠΟΔΕΚΤΟ) ΑΛΑΣ ΑΥΤΗΣ, ΕΙΔΙΚΟΤΕΡΑ ΥΔΡΟΧΛΩΡΙΚΗ NALTREXONE ΚΑΙ BUPROPION Ή ΕΝΑ ΦΑΡΜΑΚΕΥΤΙΚΩΣ ΧΡΗΣΙΜΟΠΟΙΟΥΜΕΝΟ (ΑΠΟΔΕΚΤΟ) ΑΛΑΣ ΑΥΤΗΣ, ΕΙΔΙΚΟΤΕΡΑ ΥΔΡΟΧΛΩΡΙΚΗ BUPROPION
IPC Classification
Related Documents
Related Titles
Type
Master title
Related title
[SPC]
20170402415
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
795179
OREXIGEN THERAPEUTICS, INC.
3344 NORTH TORREY PINES COURT, SUITE 200
LA JOLLA, CA 92037
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
1961878
WEBER, ECKARD
1961879
COWLEY, MICHAEL ALEXANDER
Representatives
Code
Firstname
Surname
Address
Town
Zip
3089
NIKOLAOS
LYMPERIS "DIKIGORIKI ETAIREIA VAGIANOU KOSTOPOULOU LYMPERI"
STOURNARI 37
ATHINA (ATTIKIS)
10682
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
7915
NIKOLAOS
LYMPERIS
STOURNARI 37
ATHINA (ATTIKIS)
10682
GREECE
Owners History
Title Instruments
Payments history
2 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).